Skip to main content

Unity Biotechnology, Inc.

UBXDelisted Aug 6, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001463361

Unity Biotechnology, Inc. was delisted on Aug 6, 2025; its insiders filed their last Form 4 on Apr 3, 2025; 35 institutions reported holding it in 13F filings for Q2 2025, worth $987.3K in total; no superinvestor held it.

13F holders, Q4 2025

Institutional positions in Unity Biotechnology, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

UBX is no longer listed, and 13F filings after Q2 2025 list far fewer holders. See Q2 2025

Institutional holders
0
−5 vs. Q3 2025
Shares held
0
−29.5K (−100.0%) vs. Q3 2025
Total value
$0
−$1.68K (−100.0%) vs. Q3 2025
New holders
0
0 more added
Sold out
5
0 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting UBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 0 institutions
Q1 2021: 92 institutionsQ2 2021: 98 institutionsQ3 2021: 84 institutionsQ4 2021: 72 institutionsQ1 2022: 71 institutionsQ2 2022: 66 institutionsQ3 2022: 72 institutionsQ4 2022: 54 institutionsQ1 2023: 46 institutionsQ2 2023: 40 institutionsQ3 2023: 36 institutionsQ4 2023: 42 institutionsQ1 2024: 40 institutionsQ2 2024: 39 institutionsQ3 2024: 38 institutionsQ4 2024: 37 institutionsQ1 2025: 40 institutionsQ2 2025: 35 institutionsQ3 2025: 6 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2025: $0
Q1 2021: $121.8MQ2 2021: $84.0MQ3 2021: $42.1MQ4 2021: $21.3MQ1 2022: $14.2MQ2 2022: $5.31MQ3 2022: $24.1MQ4 2022: $12.6MQ1 2023: $5.13MQ2 2023: $6.87MQ3 2023: $6.42MQ4 2023: $8.33MQ1 2024: $5.87MQ2 2024: $4.66MQ3 2024: $5.09MQ4 2024: $3.10MQ1 2025: $2.95MQ2 2025: $987.3KQ3 2025: $1.68KQ4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding UBX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20256$1.68K
Q2 202535$987.3K
Q1 202540$2.95M
Q4 202437$3.10M
Q3 202438$5.09M
Q2 202439$4.66M
Q1 202440$5.87M
Q4 202342$8.33M
Q3 202336$6.42M
Q2 202340$6.87M
Q1 202346$5.13M
Q4 202254$12.6M
Q3 202272$24.1M
Q2 202266$5.31M
Q1 202271$14.2M
Q4 202172$21.3M
Q3 202184$42.1M
Q2 202198$84.0M
Q1 202192$121.8M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Unity Biotechnology, Inc.; share changes are against Q3 2025.

Institutions holding UBX in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Advisor Group Holdings, Inc.0$00.00%−11,878−100.0%Sold out
XTX Topco Ltd0$00.00%−13,985−100.0%Sold out
Steward Partners Investment Advisory, LLC0$00.00%−1,000−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−100−100.0%Sold out
Simplex Trading, LLC0$00.00%−2,571−100.0%Sold out
AllSquare Wealth Management LLC––––Not filed